Featured Research

from universities, journals, and other organizations

Inflammation Blocks Impact Of Heart Healthy Diets For Some

Date:
July 24, 2003
Source:
Johns Hopkins Medical Institutions
Summary:
Results of a Johns Hopkins study suggest that natural chemicals released in the body as a result of chronic inflammation may underpin the failure of low-fat, so-called heart healthy diets to actually reduce cholesterol and heart disease risk in some people.

Results of a Johns Hopkins study suggest that natural chemicals released in the body as a result of chronic inflammation may underpin the failure of low-fat, so-called heart healthy diets to actually reduce cholesterol and heart disease risk in some people.

According to the study's results, published in the July 15 issue of Circulation, measuring circulating blood levels of C-reactive protein — a marker of inflammation already linked to increased risk of heart disease — may predict who might benefit from a reduced-fat, low-cholesterol diet and who might not.

For the study, a team led by Thomas "Tate" P. Erlinger, M.D., M.P.H., assistant professor of medicine, tracked 100 subjects with elevated CRP levels following a reduced-fat, low-cholesterol diet for 12 weeks. They found that overall, this group had less of a reduction in total cholesterol and low-density lipoprotein (LDL) or "bad" cholesterol levels. Subjects also had a greater increase in triglycerides compared with another group on the same diet but with lower CRP levels.

Subjects with lower CRP readings at the start of the study (less than 2.37 milligrams per liter) had a nearly 10 percent drop in total cholesterol and nearly 12 percent reduction in LDL cholesterol. Their triglycerides were not affected. In those with higher CRP (more than 2.37 mg/L), total and LDL cholesterol were lowered by only 3 percent each, while triglycerides rose by 19 percent.

Erlinger cautions that the study sample was small and did not examine the impact of weight loss on CRP levels.

"An important implication of our findings is that we may be able to use CRP testing to distinguish those who are likely to have a favorable response to a reduced-fat, low-cholesterol diet from those who will not respond well," says Erlinger. "It may also help explain why different people on the same diet may have widely varying results. It's too early for broad recommendations, but additional research in this area could help physicians tailor diets for specific patients."

While causes of inflammation vary, the condition itself has already been linked to several cardiovascular risk factors including hypertension, diabetes and elevated triglycerides. CRP has recently been identified — along with cigarette smoking and obesity — as a risk factor for cardiovascular disease.

The 100 healthy adults in the study had an average age of 52 and already were participating in the national Dietary Approaches to Stop Hypertension-Sodium (DASH-Sodium) trial.

The Hopkins team took blood samples from each participant at the study's start to measure CRP, cholesterol and triglycerides. After two weeks on a control diet of 37 percent total fat and 16 percent saturated fat, participants were assigned to continue to follow either the control diet or the DASH diet, which calls for 27 percent total fat and 6 percent saturated fat, for 12 weeks.

The study was supported by grants from the National Institutes of Health, the National Heart, Lung and Blood Institute and the General Clinical Research Center at Johns Hopkins. Co-authors were Edgar R. Miller III, M.D., Ph.D.; Jeanne Charleston, R.N.; and Lawrence J. Appel, M.D., M.P.H.

- - JHMI - -

Erlinger, Thomas P. et al, "Inflammation Modifies the Effects of a Reduced Fat, Low Cholesterol Diet on Lipids: Results from the DASH-Sodium Trial," Circulation, July 15, 2003; Vol. 108, pages 150-154.

Links:

Johns Hopkins' Welch Center for Prevention, Epidemiology and Clinical Researchhttp://www.med.jhu.edu/welchcenter/

Circulationhttp://circ.ahajournals.org/

Information on the DASH diethttp://www.nhlbi.nih.gov/health/public/heart/hbp/dash/


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "Inflammation Blocks Impact Of Heart Healthy Diets For Some." ScienceDaily. ScienceDaily, 24 July 2003. <www.sciencedaily.com/releases/2003/07/030724083515.htm>.
Johns Hopkins Medical Institutions. (2003, July 24). Inflammation Blocks Impact Of Heart Healthy Diets For Some. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2003/07/030724083515.htm
Johns Hopkins Medical Institutions. "Inflammation Blocks Impact Of Heart Healthy Diets For Some." ScienceDaily. www.sciencedaily.com/releases/2003/07/030724083515.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins